CLINICAL_TRIALS
trial_result
· 2013-02-12
Clinical Trial Update: Clinical Study to Determine if Ecopipam Can Reduce Urges to Gamble [Phase 2]
Summary
Phase 2 study assessing whether Ecopipam reduces urges to gamble in gambling disorder; the trial was completed and results were posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Emalex Biosciences Inc. | Conditions: Pathological Gambling | Phase 2 | Status: COMPLETED | Results posted: 2013-02-12